专利信息

首页 1 2 3 下页尾页共 23 条记录, 当前第1/3页。

专利标题：The use of substituted tetracyclic imidazole derivatives as anti-histaminics

专利权人：Janssen Pharmaceutica N.v.;

The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury. In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine brompheniram...

专利标题：Use of anti-histaminics for acute reduction of elevated intracranial pressure

专利标题：Novel alpha-amylase inhibitors (azatadine family compounds) and application thereof

专利权人：UNIV TIANJIN MEDICAL;

专利标题：STABILE LIQUID PHARMACEUTICAL FORMULATION

专利权人：GALENIKA A D [RS];

Invention herewith described refers to the stabile liquid pharmaceutical formulation and protects the liquid pharmaceutical formulation, syrup, eye drops or nose drops, with desloratadine or other chemically-similar tricyclic antihistamines such as loratadine, azatadine or their combination, as an active component. Novelty in formulation is based on the formation of complex structures, which occur by incorporating medicinal substances of the tricyclic antihistamine - desloratadine (loratadine, a...

专利标题：A kind of compositions that contains azatadine

专利权人：Yipinhong Pharmacy Co., Ltd.;

专利标题：Cranial internal pressure use of antihistamic agent for the acuteness decrease of shin's

The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury.In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine bromphenirami...

专利标题：The use of histamine receptor antagonists for the reduction of intracranial pressure

专利权人：Janssen Pharmaceutica, N.v.;

专利标题：The use of anti-histaminics for acute reduction of elevated intracranial pressure

The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury.In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine bromphenirami...

专利标题：Migraine-preventing medicaments comprising a mast cell degranulation blocking agent (e.g. hydroxyzine, ketotifen, azatadine, azelastine, cyproheptadine, oxatomide, terfenadine, etc)

专利权人：Kos Pharmaceuticals Inc;

专利标题：The combination of topical nasal antihistamines and topical nasal mast cell stabilizers

专利权人：Mcneil-ppc, Inc.;

Nasal spray or nasal drops for the treatment of allergic rhinitis are disclosed comprising: a. an effective amount of a topical antihistamine to relieve histamine mediated symptoms where said topical nasal antihistamine is selected from the group consisting of azelastine and azatadine; b. an effective amount of a topical mast cell stabilizer to inhibit mast cell mediator release where said topical nasal mast cell stabilizer is selected from the group consisting of cromolyn sodium nedocromil and ...

当前查询条件: [药品] 包含 'Azatadine'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. HU229118B1	2013/8/28	HU20040002357	2002/11/22
专利标题：The use of substituted tetracyclic imidazole derivatives as anti-histaminics 专利权人：Janssen Pharmaceutica N.v.; The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury. In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine brompheniram...

2. JP4991770B2	2012/8/1	JP20090023575	2009/2/4
专利标题：Use of anti-histaminics for acute reduction of elevated intracranial pressure 专利权人： The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury. In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine brompheniram...

3. CN102212089A	2011/10/12	CN2011191479	2011/4/12
专利标题：Novel alpha-amylase inhibitors (azatadine family compounds) and application thereof 专利权人：UNIV TIANJIN MEDICAL;

4. RS20090393A	2011/8/31	RS2009P000393	2009/9/4
专利标题：STABILE LIQUID PHARMACEUTICAL FORMULATION 专利权人：GALENIKA A D [RS]; Invention herewith described refers to the stabile liquid pharmaceutical formulation and protects the liquid pharmaceutical formulation, syrup, eye drops or nose drops, with desloratadine or other chemically-similar tricyclic antihistamines such as loratadine, azatadine or their combination, as an active component. Novelty in formulation is based on the formation of complex structures, which occur by incorporating medicinal substances of the tricyclic antihistamine - desloratadine (loratadine, a...

5. CN101810615A	2010/8/25
专利标题：A kind of compositions that contains azatadine 专利权人：Yipinhong Pharmacy Co., Ltd.;

6. JP4505226B2	2010/7/21	JP20030545660	2002/11/22
专利标题：Cranial internal pressure use of antihistamic agent for the acuteness decrease of shin's 专利权人： The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury.In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine bromphenirami...

7. EP1832287A3	2007/12/26	EP20070107669	2002/11/22
专利标题：The use of histamine receptor antagonists for the reduction of intracranial pressure 专利权人：Janssen Pharmaceutica, N.v.; The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury. In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine brompheniram...

8. JP2005509680A	2005/4/14	JP20030545660	2002/11/22
专利标题：The use of anti-histaminics for acute reduction of elevated intracranial pressure 专利权人： The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP) in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia in particular caused by brain injury more in particular caused by traumatic (TBI) and non-traumatic brain injury.In particular the histamine antagonist is selected from the group of acrivastine alimemazine antazoline astemizole azatadine azelastine bromphenirami...

9. NZ246748A	1999/5/28	NZ19920246748	1992/12/28
专利标题：Migraine-preventing medicaments comprising a mast cell degranulation blocking agent (e.g. hydroxyzine, ketotifen, azatadine, azelastine, cyproheptadine, oxatomide, terfenadine, etc) 专利权人：Kos Pharmaceuticals Inc;

10. WO9701340A1	1997/1/16	WO1996US10810	1996/6/25
专利标题：The combination of topical nasal antihistamines and topical nasal mast cell stabilizers 专利权人：Mcneil-ppc, Inc.; Nasal spray or nasal drops for the treatment of allergic rhinitis are disclosed comprising: a. an effective amount of a topical antihistamine to relieve histamine mediated symptoms where said topical nasal antihistamine is selected from the group consisting of azelastine and azatadine; b. an effective amount of a topical mast cell stabilizer to inhibit mast cell mediator release where said topical nasal mast cell stabilizer is selected from the group consisting of cromolyn sodium nedocromil and ...

下载范围

下载内容